Sinovac Biotech, Overview
Sinovac Biotech, Discounted Cash Flow
DCF Analysis for SVA.
Get informed when a big investor buys or sells
+ FollowFair Value
$15.63
Current Fair Value
$15.63
↑ 141.6% Upside
Undervalued by 141.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison